Hello and Welcome to Patientsville.com, Your Source for all ZOPHREN information. We are dedicated to provide You with ZOPHREN safety information. Learn about ZOPHREN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
ZOPHREN Safety Reports
Total ZOPHREN reports: 27.ZOPHREN FDA safety alerts: 2002 2003 2005 .
Reported deaths: 6 Reported hospitalizations: 18.
Take ZOPHREN Side Effects Survey or Share Your ZOPHREN Story. Read More Here.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Feb 28, 2007. Female patient, 55 years of age, weighting 174.2 lb, was treated with ZOPHREN. ZOPHREN dosage: unknown. During the same period patient was treated with COUMADIN, FLUOROURACIL, CAMPTOSAR, AVASTIN. Patient died on 01/25/2007.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Mar 22, 2007. Male patient, child 6 years of age, weighting 44.09 lb, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, blood pressure increased, cyanosis, face oedema, fatigue, malaise, nausea, panic reaction, tachycardia. ZOPHREN dosage: 4MG PER DAY. During the same period patient was treated with UROMITEXAN, ETOPOPHOS. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Mar 22, 2007. Female patient, child 6 years of age, weighting 63.93 lb, was diagnosed with optic tract glioma and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, angioedema, cyanosis, diarrhoea, erythema, face oedema, hypotension, hypotonia, malaise. ZOPHREN dosage: 4MG CYCLIC. During the same period patient was treated with ONCOVIN, CARBOPLATIN. Patient was hospitalized. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Apr 12, 2007. Female patient, 88 years of age, was diagnosed with vomiting and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: eosinophilia, face oedema, inflammation, lymphopenia, pyrexia, rash pustular, skin lesion. ZOPHREN dosage: unknown. During the same period patient was treated with RIFADIN, ATHYMIL, OMEPRAZOLE, VANCOMYCIN, PARACETAMOL, LOVENOX. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Apr 12, 2007. Female patient, 55 years of age, weighting 174.2 lb, was diagnosed with thrombosis prophylaxis and was treated with ZOPHREN. ZOPHREN dosage: unknown. During the same period patient was treated with COUMADIN, FLUOROURACIL, CAMPTOSAR, AVASTIN. Patient died on 01/25/2007.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Apr 17, 2007. Female patient, 35 years of age, weighting 143.3 lb, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: body temperature increased, cholestasis, fatigue, hepatocellular damage, nasopharyngitis. ZOPHREN dosage: unknown. During the same period patient was treated with SOLUPRED, FARMORUBICINE, ANAUSIN METOCLOPRAMIDE, ADVIL, TAXOTERE, NEULASTA. Patient was hospitalized. Patient recovered.
Physician from FRANCE reported ZOPHREN problem on Apr 16, 2007. Female patient, 30 years of age, was diagnosed with vomiting in pregnancy and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: abortion induced. ZOPHREN dosage: unknown. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Apr 19, 2007. Female patient, 63 years of age, was diagnosed with prophylaxis of nausea and vomiting, breast cancer and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: angiodermatitis, escherichia sepsis, haemolytic anaemia, haemolytic uraemic syndrome, lividity, necrosis, paraneoplastic syndrome, red blood cell schistocytes present, renal failure. ZOPHREN dosage: unknown. During the same period patient was treated with SERESTA, OSMOTAN, DAFLON, GEMZAR. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Apr 17, 2007. Female patient, 41 years of age, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: cough, cryptogenic organising pneumonia, dyspnoea at rest, hypoxia, obstructive airways disorder, orthopnoea, rales, restrictive pulmonary disease. ZOPHREN dosage: unknown. During the same period patient was treated with ENDOXAN, PRIMPERAN, FARMORUBICINE, FLUOROURACIL, MEDROL. Patient was hospitalized. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on June 02, 2006. Male patient, child 11 years of age, weighting 141.1 lb, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: hyponatraemia, inappropriate antidiuretic hormone secretion, malaise, weight increased. ZOPHREN dosage: unknown. During the same period patient was treated with PLITICAN, ONCOVIN, CARBOPLATIN, BACTRIM, ETOPOSIDE. Patient was hospitalized. Patient recovered.
Pharmacist from FRANCE reported ZOPHREN problem on May 19, 2006. Female patient, 41 years of age, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest. ZOPHREN dosage: 16MG CYCLIC. During the same period patient was treated with GRANOCYTE, VOGALENE, METOCLOPRAMIDE, DURAGESIC, CONTRAMAL, OLICLINOMEL. Patient died.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on July 18, 2006. Female patient, 78 years of age, weighting 134.5 lb, was diagnosed with nausea, breast cancer and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: dyspnoea. ZOPHREN dosage: unknown. During the same period patient was treated with RANIPLEX, POLARAMINE, GEMZAR, NITRODERM, DIFFU, DIGOXIN, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on July 25, 2006. Female patient, 34 years of age, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: chills, leukocytosis, placental disorder. ZOPHREN dosage: unknown. During the same period patient was treated with IFOSFAMIDE, MESNA, DEXAMETHASONE, DOXORUBICIN. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on July 31, 2006. Male patient, 66 years of age, was diagnosed with myeloma recurrence and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: neuropathy peripheral, orthostatic hypotension. ZOPHREN dosage: unknown. During the same period patient was treated with LEXOMIL, VELCADE, METEOSPASMYL, MOVICOL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on July 18, 2006. Female patient, 78 years of age, weighting 134.5 lb, was diagnosed with nausea, breast cancer and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, dyspnoea, obstructive airways disorder, restrictive pulmonary disease. ZOPHREN dosage: unknown. During the same period patient was treated with RANIPLEX, POLARAMINE, GEMZAR, NITRODERM, DIFFU, DIGOXIN, OMEPRAZOLE. Patient was hospitalized and became disabled. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Aug 08, 2006. Female patient, 56 years of age, weighting 132.3 lb, was diagnosed with vomiting, bradycardia and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: angina pectoris, atrial fibrillation, bradycardia, chest pain, electrocardiogram repolarisation abnormality, hypotension, myocardial ischaemia, troponin increased. ZOPHREN dosage: 4MG SINGLE DOSE. During the same period patient was treated with ATROPINE. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Aug 21, 2006. Female patient, 63 years of age, weighting 125.7 lb, was diagnosed with ovarian cancer and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: erythema, palmar erythema, rash. ZOPHREN dosage: 8MG CYCLIC. During the same period patient was treated with ENDOXAN, CARBOPLATIN. Patient was hospitalized. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Aug 28, 2006. Female patient, 49 years of age, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: neutropenia, rash erythematous. ZOPHREN dosage: 16MG PER DAY. During the same period patient was treated with RANIPLEX, POLARAMINE, PACLITAXEL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Aug 30, 2006. Female patient, 80 years of age, weighting 200.6 lb, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: chills, enterobacter infection, hypersensitivity, nausea, oedema peripheral, pruritus, purpura, pyrexia, rash erythematous. ZOPHREN dosage: unknown. During the same period patient was treated with CARBOPLATIN, TENORMIN, AMLODIPINE BESYLATE, GLUCOPHAGE, ASPEGIC, PRAVASTATIN. Patient was hospitalized. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Aug 30, 2006. Female patient, weighting 22.05 lb, was diagnosed with nausea, gout, agranulocytosis and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: acute pulmonary oedema, bone marrow failure, cardiac arrest, cardiac failure, tachycardia, tachypnoea. ZOPHREN dosage: 4MG TWICE PER DAY. During the same period patient was treated with ARACYTINE, DAUNOXOME, ELITEK, FLUDARABINE, GRANOCYTE, CARDIOXANE, PLITICAN, BACTRIM. Patient was hospitalized. Patient died.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Oct 13, 2005. Male patient, 51 years of age, weighting 143.3 lb, was diagnosed with non-small cell lung cancer metastatic and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: anxiety, asthenia, chest x-ray abnormal, dyspnoea, hypoxia, interstitial lung disease, obstructive airways disorder, respiratory distress. ZOPHREN dosage: 8MG PER DAY. During the same period patient was treated with LAROXYL, PARACETAMOL, CISPLATIN, TAXOTERE, SKENAN, MORPHINE SULPHATE, MEDROL. Patient died on 09/24/2005.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Aug 28, 2006. Female patient, 49 years of age, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: neutropenia, rash erythematous. ZOPHREN dosage: 16MG PER DAY. During the same period patient was treated with RANIPLEX, POLARAMINE, PACLITAXEL. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Sept 05, 2006. Female patient, 54 years of age, weighting 130.1 lb, was diagnosed with peritoneal carcinoma and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: anuria, blood lactate dehydrogenase increased, oliguria, renal failure acute, renal tubular necrosis, renal vein thrombosis. ZOPHREN dosage: 8MG PER DAY. During the same period patient was treated with ATROPINE, ELVORINE, CAMPTOSAR, AVASTIN, FLUOROURACIL. Patient was hospitalized. Patient died.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Sept 05, 2006. Male patient, child 2 years of age, weighting 26.46 lb, was diagnosed with nephroblastoma and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: erythema, extravasation, injection site oedema, oedema peripheral. ZOPHREN dosage: 4MG PER DAY. During the same period patient was treated with ONCOVIN, COSMEGEN, LOXEN, TRANDATE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on Sept 12, 2006. Female patient, 62 years of age, weighting 205.0 lb, was diagnosed with essential hypertension, ovarian cancer and was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: dermatitis bullous. ZOPHREN dosage: unknown. During the same period patient was treated with CHRONADALATE, CAELYX. Patient was hospitalized. Patient recovered.
ZOPHREN problem was reported by a Consumer or non-health professional from FRANCE on Dec 20, 2005. Male patient, child 9 years of age, weighting 61.73 lb, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: ascites, hepatocellular damage, hepatomegaly, pleural effusion, respiratory distress. ZOPHREN dosage: 4MG PER DAY. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, CARBOPLATIN, CISPLATIN, VINCRISTINE, BACTRIM DS, NEUPOGEN. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from FRANCE reported ZOPHREN problem on July 25, 2006. Female patient, 34 years of age, was treated with ZOPHREN. After drug was administered, patient experienced the following problems/side effects: chills, leukocytosis, placental disorder. ZOPHREN dosage: unknown. During the same period patient was treated with IFOSFAMIDE, MESNA, DEXAMETHASONE, DOXORUBICIN. Patient recovered.